Literature DB >> 11447051

Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children.

M R Rao1, A B Naficy, S J Savarino, R Abu-Elyazeed, T F Wierzba, L F Peruski, I Abdel-Messih, R Frenck, J D Clemens.   

Abstract

Campylobacter infection in developing countries has not received much public health attention because of the observation that infections are not associated with disease beyond the first 6 months of life. A cohort of 397 Egyptian children aged less than 3 years, who were observed twice weekly during 1995--1998, experienced an incidence of 0.6 episodes of Campylobacter diarrhea per child-year. A total of 13% of the Campylobacter diarrheal episodes were characterized by severe dehydration. Age-specific incidence rates (episodes per year) were 0.9 in infants aged less than 6 months, 1.5 in those 6--12 months, and 0.4 and 0.2 in the second and third years of life, respectively. Convalescent excretion of Campylobacter after a diarrheal episode might be enhancing transmission and contributing to this high incidence. Observed risk factors for Campylobacter diarrhea were poor hygienic conditions and the presence of animals in the house. Regardless of the child's age, a first infection by Campylobacter was associated with diarrhea (odds ratio = 2.45; 95% confidence interval: 1.61, 3.71); however, subsequent infections were associated with diarrhea only in children aged less than 6 months. This observation that natural infection did not confer protection during the first 6 months of life poses a challenge to vaccine development.

Entities:  

Mesh:

Year:  2001        PMID: 11447051     DOI: 10.1093/aje/154.2.166

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  43 in total

1.  Detection of Campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries.

Authors:  James A Platts-Mills; Jie Liu; Jean Gratz; Esto Mduma; Caroline Amour; Ndealilia Swai; Mami Taniuchi; Sharmin Begum; Pablo Peñataro Yori; Drake H Tilley; Gwenyth Lee; Zeli Shen; Mark T Whary; James G Fox; Monica McGrath; Margaret Kosek; Rashidul Haque; Eric R Houpt
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

Review 2.  Update on the burden of Campylobacter in developing countries.

Authors:  James A Platts-Mills; Margaret Kosek
Journal:  Curr Opin Infect Dis       Date:  2014-10       Impact factor: 4.915

3.  The internal transcribed spacer region, a new tool for use in species differentiation and delineation of systematic relationships within the Campylobacter genus.

Authors:  Si Ming Man; Nadeem O Kaakoush; Sophie Octavia; Hazel Mitchell
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

Review 4.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  Occurrences of thermophilic Campylobacter in pigs slaughtered at Morogoro slaughter slabs, Tanzania.

Authors:  Robinson H Mdegela; Kibona Laurence; Petro Jacob; Hezron Emmanuel Nonga
Journal:  Trop Anim Health Prod       Date:  2010-08-21       Impact factor: 1.559

6.  Comparison of Cape Town and Skirrow's Campylobacter isolation protocols in humans and broilers in Morogoro, Tanzania.

Authors:  Petro Jacob; Robinson H Mdegela; Hezron Emmanuel Nonga
Journal:  Trop Anim Health Prod       Date:  2011-02-26       Impact factor: 1.559

7.  Discrimination of major capsular types of Campylobacter jejuni by multiplex PCR.

Authors:  Frédéric Poly; Oralak Serichatalergs; Marc Schulman; Jennifer Ju; Cory N Cates; Margaret Kanipes; Carl Mason; Patricia Guerry
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

Review 8.  The Data Behind Risk Analysis of Campylobacter Jejuni and Campylobacter Coli Infections.

Authors:  Racem Ben Romdhane; Roswitha Merle
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

9.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 10.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.